Association of serum pneumoproteins with clinical course of COPD

M. Suzuki (Tokyo, Japan)

Source: International Congress 2017 – COPD biomarkers
Session: COPD biomarkers
Session type: Thematic Poster
Number: 3615
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Suzuki (Tokyo, Japan). Association of serum pneumoproteins with clinical course of COPD. 3615

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of serum bilirubin and clinical outcomes in COPD
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019


Serum Club cell16 levels as a biomarker in tobacco-smoke COPD and biomass-smoke COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Association of airway bacterial load with serum CRP and fibrinogen in stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006

Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011

Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Association between serum YKL-40 and chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008

Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPD
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011

Association between serum leptin and asthma in women
Source: Annual Congress 2009 - Risk factors for asthma and pneumonia
Year: 2009

Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014

Time course of serum interleukin-6 during COPD exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011


Evaluation of serum troponin level in exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

Profile of serum vitamin D levels in stable COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Time course of sputum and serum interleukin-6 during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 464s
Year: 2005

Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013